An investor reports 1.69M Arcturus Therapeutics (ARCT) shares, with voting power over fewer shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Amova Asset Management Americas, Inc. has filed an amended ownership report (SCHEDULE 13G/A) for Arcturus Therapeutics Holdings Inc. (ARCT), disclosing beneficial ownership of 1,689,107 shares, representing 5.9% of the class, as of September 30, 2026. The report indicates shared voting power over 1,459,991 shares and shared dispositive power over all 1,689,107 shares, with no sole voting or dispositive power.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.